REY ANTONIO APONTE-RIVERA

Allopathic & Osteopathic Physicians|Internal Medicine MAYAGUEZ, PR NPI 1003401191

General Payments — all program years on this page

$1,095.19

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $360.91 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $360.9113

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $20.051
2022 $271.9512
2023 $442.2815
2024 $360.9113

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078168561 Janssen Pharmaceuticals, Inc $18.19 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078168615 Janssen Pharmaceuticals, Inc $22.30 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078168725 Janssen Pharmaceuticals, Inc $38.96 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086257258 Bayer Puerto Rico Inc. $20.33 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086676583 Novartis Pharmaceuticals Corporation $19.19 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086676585 Novartis Pharmaceuticals Corporation $18.58 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086676597 Novartis Pharmaceuticals Corporation $27.05 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086676601 Novartis Pharmaceuticals Corporation $24.92 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104216839 AstraZeneca Pharmaceuticals LP $18.69 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105446241 AstraZeneca Pharmaceuticals LP $25.11 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115427073 Amgen Inc. $64.87 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154207522 Fresenius USA Marketing, Inc. $18.12 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154207524 Fresenius USA Marketing, Inc. $44.60 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.